Capital Fund Management S.A. Voyager Therapeutics, Inc. Transaction History

Capital Fund Management S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$10.01 - $13.75 $175,385 - $240,913	-17,521 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$8.05 - $14.21 $333,559 - $588,805	-41,436 Reduced 70.28%	17,521 $221,000
Q1 2020 May 13, 2020	SELL	$6.8 - $14.66 $119,360 - $257,326	-17,553 Reduced 22.94%	58,957 $539,000
Q4 2019 Feb 13, 2020	BUY	$12.82 - $16.85 $980,858 - $1.29 Million	76,510 New	76,510 $1.07 Million

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $219M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.